ATE417063T1 - Sekretierte transmembranproteine und dafür kodierende nukleinsäuren - Google Patents

Sekretierte transmembranproteine und dafür kodierende nukleinsäuren

Info

Publication number
ATE417063T1
ATE417063T1 AT05011885T AT05011885T ATE417063T1 AT E417063 T1 ATE417063 T1 AT E417063T1 AT 05011885 T AT05011885 T AT 05011885T AT 05011885 T AT05011885 T AT 05011885T AT E417063 T1 ATE417063 T1 AT E417063T1
Authority
AT
Austria
Prior art keywords
polypeptides
nucleic acids
present
transmembrane proteins
acids coding
Prior art date
Application number
AT05011885T
Other languages
English (en)
Inventor
Luc Desnoyers
Dan L Eaton
Audrey Goddard
Paul J Godowski
Austin L Gurney
James Pan
Timothy A Stewart
Colin K Watanabe
William I Wood
Zemin Zhang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE417063T1 publication Critical patent/ATE417063T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
AT05011885T 1999-03-23 2000-03-01 Sekretierte transmembranproteine und dafür kodierende nukleinsäuren ATE417063T1 (de)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US12577499P 1999-03-23 1999-03-23
US12577899P 1999-03-23 1999-03-23
US12582699P 1999-03-24 1999-03-24
US12703599P 1999-03-31 1999-03-31
US12770699P 1999-04-05 1999-04-05
US13035999P 1999-04-21 1999-04-21
US13127299P 1999-04-27 1999-04-27
US13127099P 1999-04-27 1999-04-27
US13129199P 1999-04-27 1999-04-27
US13237199P 1999-05-04 1999-05-04
US13238399P 1999-05-04 1999-05-04
US13237999P 1999-05-04 1999-05-04
US13575099P 1999-05-25 1999-05-25
US13816699P 1999-06-08 1999-06-08
US14479199P 1999-07-20 1999-07-20
US14697099P 1999-08-03 1999-08-03
US17026299P 1999-12-09 1999-12-09

Publications (1)

Publication Number Publication Date
ATE417063T1 true ATE417063T1 (de) 2008-12-15

Family

ID=27586019

Family Applications (4)

Application Number Title Priority Date Filing Date
AT06005614T ATE449108T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembrane polypeptide und dafür kodierende nukleinsäure
AT00917717T ATE329023T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure
AT05011885T ATE417063T1 (de) 1999-03-23 2000-03-01 Sekretierte transmembranproteine und dafür kodierende nukleinsäuren
AT05014619T ATE409228T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT06005614T ATE449108T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembrane polypeptide und dafür kodierende nukleinsäure
AT00917717T ATE329023T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05014619T ATE409228T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure

Country Status (11)

Country Link
EP (4) EP1688430B1 (de)
JP (8) JP4174183B2 (de)
KR (1) KR100504305B1 (de)
AT (4) ATE449108T1 (de)
AU (1) AU764092B2 (de)
CA (1) CA2361221A1 (de)
DK (3) DK1616878T3 (de)
ES (3) ES2314521T3 (de)
NZ (3) NZ527292A (de)
PT (3) PT1169442E (de)
WO (1) WO2000056889A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US7125959B2 (en) 1998-05-15 2006-10-24 Genentech, Inc. PRO4405 polypeptides
IL143593A0 (en) 1998-12-23 2002-04-21 Genentech Inc Il-1 related polypeptides
US7842458B2 (en) * 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
ES2317846T3 (es) 1999-08-12 2009-05-01 Agensys, Inc. Antigeno transmembranal de lectina tipo c en el cancer de prostata humano y usos del mismo.
EP1255837A2 (de) * 2000-02-08 2002-11-13 Amgen Inc. Il-17 ähnliche moleküle und ihre verwendungen
WO2001061004A1 (fr) * 2000-02-15 2001-08-23 Chugai Seiyaku Kabushiki Kaisha Nouvelle proteine comportant une sequence signal
AU2001233957A1 (en) * 2000-02-24 2001-09-03 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (bad) and unipolar depression
WO2001073022A1 (fr) * 2000-03-29 2001-10-04 Kyowa Hakko Kogyo Co., Ltd. Gene associe a la glomerulonephrite proliferative
EP1339845A2 (de) 2000-12-07 2003-09-03 ZymoGenetics, Inc. Complement-verwandtes protein zacrp3x2 aus adipozyten
EP1354950A4 (de) * 2000-12-28 2005-01-12 Asahi Kasei Pharma Corp Nf-kb aktivierendes gen
EP1397383A2 (de) * 2001-06-20 2004-03-17 Genentech, Inc. Ausgeschiedene proteine und deren verwendungen in die behandlung von knochenkrankheiten
EP1513875A2 (de) * 2002-05-10 2005-03-16 Serono Genetics Institute S.A. Krib polynukleotide und polypeptide sowie deren verwendung zur behandlung von stoffwechselkrankheiten
WO2003102182A1 (en) * 2002-05-31 2003-12-11 Hidetoshi Inoko Inflammatory skin disease-related slurp-2 gene and utilization thereof
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
EP2069793B9 (de) 2006-08-29 2017-08-16 Oxford BioTherapeutics Ltd Identifizierung von mit hepatozellulärem karzinom, glioblastom und lungenkrebs assoziiertem protein
UA102891C2 (uk) 2009-03-05 2013-08-27 Медарекс, Інк. Повні людські антитіла, специфічні до cadm1
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
KR101695792B1 (ko) * 2014-09-04 2017-01-12 디오셀 주식회사 신규 세포막 투과 펩티드 및 생리활성 물질 전달체로서의 그의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
US6001970A (en) * 1994-11-07 1999-12-14 Merck & Co., Inc Modified human neuropeptide Y1 Receptors
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
ES2287979T3 (es) * 1997-08-01 2007-12-16 Serono Genetics Institute S.A. Est 5' para proteinas secretadas identificadas a partir de tejidos cerebrales.
CA2296287A1 (en) * 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins expressed in prostate
CA2311572A1 (en) * 1997-12-17 1999-06-24 Genset S.A. Extended cdnas for secreted proteins
CA2319089A1 (en) * 1998-04-09 1999-10-21 Genset S.A. 5' ests and encoded human proteins
AU758074B2 (en) * 1998-04-29 2003-03-13 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
AU3124000A (en) * 1998-12-17 2000-07-03 Human Genome Sciences, Inc. 47 human secreted proteins
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'
CA2377263A1 (en) * 1999-06-23 2000-12-28 Curagen Corporation Polynucleotides and polypeptides encoded thereby
EP1074617A3 (de) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
ES2317846T3 (es) * 1999-08-12 2009-05-01 Agensys, Inc. Antigeno transmembranal de lectina tipo c en el cancer de prostata humano y usos del mismo.
EP1206536A2 (de) * 1999-08-17 2002-05-22 Sagami Chemical Research Center Menschliche proteine mit hydrophoben domänen und dafür kodierende dnas
US6635742B1 (en) * 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides

Also Published As

Publication number Publication date
WO2000056889A3 (en) 2001-04-26
JP4398937B2 (ja) 2010-01-13
JP2006158392A (ja) 2006-06-22
KR20010112927A (ko) 2001-12-22
JP4174183B2 (ja) 2008-10-29
PT1169442E (pt) 2006-10-31
NZ527292A (en) 2005-03-24
DK1616878T3 (da) 2009-03-30
ATE409228T1 (de) 2008-10-15
ATE449108T1 (de) 2009-12-15
PT1616878E (pt) 2009-03-18
EP1688430A3 (de) 2006-11-02
JP2006101881A (ja) 2006-04-20
ES2319202T3 (es) 2009-05-05
EP1616878B1 (de) 2008-12-10
EP1616878A1 (de) 2006-01-18
ES2314521T3 (es) 2009-03-16
EP1688430B1 (de) 2009-11-18
DK1169442T3 (da) 2006-10-16
JP4392760B2 (ja) 2010-01-06
JP2006101880A (ja) 2006-04-20
PT1609863E (pt) 2009-01-02
JP2003527074A (ja) 2003-09-16
JP2006115847A (ja) 2006-05-11
EP1169442A2 (de) 2002-01-09
ATE329023T1 (de) 2006-06-15
NZ527293A (en) 2005-01-28
JP4402034B2 (ja) 2010-01-20
AU3864800A (en) 2000-10-09
DK1609863T3 (da) 2008-12-15
EP1609863A2 (de) 2005-12-28
AU764092B2 (en) 2003-08-07
EP1688430A2 (de) 2006-08-09
KR100504305B1 (ko) 2005-07-28
NZ536320A (en) 2006-04-28
CA2361221A1 (en) 2000-09-28
ES2269125T3 (es) 2007-04-01
EP1609863A3 (de) 2006-04-12
EP1609863B1 (de) 2008-09-24
JP2006136325A (ja) 2006-06-01
JP2006115848A (ja) 2006-05-11
WO2000056889A2 (en) 2000-09-28
JP2010075189A (ja) 2010-04-08
JP4392759B2 (ja) 2010-01-06
EP1169442B1 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
ATE478145T1 (de) Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
ATE447583T1 (de) Polypeptide und dafür kodierende nukleinsäure
ATE417063T1 (de) Sekretierte transmembranproteine und dafür kodierende nukleinsäuren
KR100468977B1 (ko) 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
ATE300553T1 (de) Sekretiertes polypeptide und dafür kodierende nukleinsäuren
ATE321136T1 (de) Sekretierte und transmembrane polypeptide und dafür kodierende nukleinsäuren
DE69932266D1 (de) Sekretiertes und transmembranes Polypeptid und dafür kodierende Nukleinsäure
ATE396201T1 (de) Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure
DE60043242D1 (de) Ausgeschiedene und transmembrane Polypeptide und dafür kodierende Nukleinsäure
ATE363537T1 (de) Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure
ATE380864T1 (de) Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure
DK1241180T3 (da) Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette
ATE282047T1 (de) Polypeptide und dafür kodierende nukleinsäure
ATE291085T1 (de) Polypeptide und dafür kodierende nukleinsäure
ATE268819T1 (de) Pro241 polypeptide und dafür kodierende nukleinsäuren
DK1241184T3 (da) Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette
DK1241183T3 (da) Humant HCAR-agtig protein og nucleinsyrer kodende derfor
ATE290018T1 (de) Polypeptid und dafür kodieredes nukleinsäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1616878

Country of ref document: EP

REN Ceased due to non-payment of the annual fee